RxDoctor Payments Data

Rizwan Hamid

Clinical Genetics (M.D.) · Nashville, TNNPI 1326122441

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Takeda Pharmaceuticals U.S.A., Inc..

$45in general payments, 2019–2025

Across 2 payments — averaging $22.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$45
$968,435in research payments, 2019–2025

Across 36 payments — averaging $26,901 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$914K
  • Shire North American Group Inc$55K

What the payments were for

  • Food & beverage$45100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Takeda Pharmaceuticals U.S.A., Inc.2$45

How this compares

Too few clinical genetics (m.d.) providers in Tennesseeto place this figure against a meaningful peer group, so we don't.

Other clinical genetics (m.d.) in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →